Compare AMR & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMR | LMAT |
|---|---|---|
| Founded | 2016 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Coal Mining | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.2B |
| IPO Year | 2017 | 2006 |
| Metric | AMR | LMAT |
|---|---|---|
| Price | $201.15 | $91.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $181.50 | $105.80 |
| AVG Volume (30 Days) | 234.7K | ★ 246.0K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 0.93% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 0.68 |
| Revenue | ★ $2,129,481,000.00 | $249,602,000.00 |
| Revenue This Year | $15.05 | $14.21 |
| Revenue Next Year | $14.78 | $8.88 |
| P/E Ratio | ★ N/A | $135.79 |
| Revenue Growth | N/A | ★ 13.53 |
| 52 Week Low | $104.42 | $79.01 |
| 52 Week High | $253.82 | $118.01 |
| Indicator | AMR | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 52.73 | 35.10 |
| Support Level | $198.13 | $89.81 |
| Resistance Level | $212.15 | $92.25 |
| Average True Range (ATR) | 13.44 | 2.86 |
| MACD | -0.77 | 0.21 |
| Stochastic Oscillator | 51.76 | 16.39 |
Alpha Metallurgical Resources Inc is a Tennessee-based coal mining company with operations across Virginia and West Virginia. The company's portfolio of mining operations consists of underground mines, surface mines, and coal preparation plants. It produces low-ash metallurgical coal, including High-Vol. A, Mid-Vol., High-Vol. B, and Low-Vol. coal, which is shipped to domestic and international coke and steel producers. The reportable segment of the company is Met. It extracts, processes and markets met and thermal coal from deep and surface mines for sale to steel and coke producers, industrial customers, and electric utilities.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.